ADD CONDITION

items per page

Ourui One Facial Bump Refining Essence

Last content change checked dailysee data sync status

Active ingredient
Salicylic Acid 0.25 g/100 mL
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2026
Label revision date
January 27, 2026
Active ingredient
Salicylic Acid 0.25 g/100 mL
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2026
Label revision date
January 27, 2026
Manufacturer
Jiangxi Yudexi Pharmaceutical Co. , LTD
Registration number
M006
NDC root
85248-011

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This drug is designed to help improve the texture of your skin by promoting gentle exfoliation. Exfoliation is the process of removing dead skin cells from the surface, which can lead to a smoother and more radiant appearance. If you're looking to enhance your skin's overall look and feel, this product may be a beneficial addition to your skincare routine.

Uses

If you're looking to improve the texture of your skin, this product can help by gently exfoliating the surface. Exfoliation is the process of removing dead skin cells, which can lead to a smoother and more radiant appearance. By using this product, you can achieve a softer skin texture, making it feel fresher and more vibrant.

Dosage and Administration

To get the best results from your treatment, start by applying the essence daily after you cleanse and tone your skin. For optimal effectiveness, use it twice a day for at least four weeks.

When you're ready to apply, dispense a small amount—about the size of a pea—onto the area that needs attention. Use your fingertips to gently massage the essence into your skin until it is fully absorbed. Keep using the product for as long as necessary, until you notice that the skin bumps (papules) no longer appear.

What to Avoid

It's important to be aware of certain situations where you should not use this medication. Specifically, you should avoid using it if you are caring for children under 2 years old, as it is not safe for them. Additionally, do not apply this medication to open skin wounds, as this can lead to complications.

By following these guidelines, you can help ensure your safety and the safety of others. If you have any questions or concerns about using this medication, please consult your healthcare provider for more information.

Side Effects

If you experience any rash or irritation while using this product, it’s important to stop using it immediately and consult your doctor. This is a precaution to ensure your safety and well-being. Remember, this product is intended for external use only, so please follow these guidelines carefully.

Warnings and Precautions

This product is for external use only. If you experience any rash or irritation while using it, stop using the product and consult your doctor.

In case of accidental swallowing, seek emergency medical help or contact the Poison Control Center immediately. It's important to take these precautions seriously to ensure your safety while using this product.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that there is no information available about the use of this medication during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions related to pregnancy have not been addressed.

Given this lack of information, it is crucial to consult with your healthcare provider before using this medication. They can help you understand any potential risks and make informed decisions about your treatment options during pregnancy.

Lactation Use

When it comes to breastfeeding, it's important to note that the drug insert does not provide specific information about nursing mothers or lactation. This means that there are no established guidelines or data regarding the safety or effects of this medication while breastfeeding.

If you are breastfeeding or planning to breastfeed, it's always a good idea to consult with your healthcare provider for personalized advice and to discuss any potential risks or concerns related to your medication. Your healthcare provider can help you make informed decisions that prioritize both your health and your baby's well-being.

Pediatric Use

It's important to be cautious when considering this medication for your child. You should not use it in children who are younger than 2 years old, as it is not safe for that age group. Always consult with your child's healthcare provider for guidance on appropriate treatments and dosages based on their specific age and health needs.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific situation. They can help determine the best approach based on your liver function and overall health.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any tests you might be undergoing. This way, you can avoid any potential issues and ensure the best possible care.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, shady place. This helps maintain its effectiveness and prevents any potential damage. When handling the product, be sure to do so with clean hands and in a sterile field (a clean area free from germs) to avoid contamination.

If you have any specific disposal instructions, please follow them carefully to ensure safe and responsible disposal. Always keep the product out of reach of children to prevent accidental misuse.

Additional Information

You should apply this medication topically, meaning it is meant to be used on the skin. For best results, cleanse and tone your skin first, then apply the medication daily. It is recommended to use it twice a day for at least four weeks to see the desired effects.

FAQ

What does this drug do?

The drug aids in smoothing skin texture through gentle exfoliation.

How should I apply the drug?

Apply a pea-size amount onto the problematic area after cleansing and toning, using your fingertips to massage until fully absorbed.

How often should I use this drug?

You should use it twice a day for at least 4 weeks.

What should I do if I experience irritation or rash?

Stop using the drug and ask a doctor if irritation or rash occurs.

Is this drug safe for children?

Do not use this drug in children less than 2 years old.

Can I use this drug on open skin wounds?

No, do not use it on open skin wounds.

What should I do if I swallow the drug?

If swallowed, get medical help or contact the Poison Control Center right away.

Where should I store this drug?

Store it in a cool, shady place.

Packaging Info

Below are the non-prescription pack sizes of Ourui One Facial Bump Refining Essence (salicylic acid 0.25% facial bump refining essence). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Ourui One Facial Bump Refining Essence.
Details

Drug Information (PDF)

This file contains official product information for Ourui One Facial Bump Refining Essence, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the improvement of skin texture through gentle exfoliation. It is designed to aid in the smoothing of the skin, making it suitable for individuals seeking to enhance the overall appearance and feel of their skin.

Dosage and Administration

Healthcare professionals are advised to instruct patients to apply the essence daily after cleansing and toning the skin. For optimal results, it is recommended to use the essence twice a day for a minimum duration of 4 weeks.

Patients should dispense a pea-sized amount of the essence onto the affected area and utilize their fingertips to gently massage the product into the skin until it is fully absorbed. Continued use is encouraged for a period of time until the appearance of skin papules ceases.

Contraindications

Use is contraindicated in children under 2 years of age due to the potential for adverse effects in this population. Additionally, application on open skin wounds is contraindicated to prevent the risk of infection and other complications associated with compromised skin integrity.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to discontinue use and seek medical attention if a rash or irritation develops.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

It is imperative to monitor patients for any signs of irritation or rash during treatment. Should these symptoms arise, patients must be instructed to stop using the product and consult their healthcare provider for further evaluation and management.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event of rash or irritation, it is advised to discontinue use and consult a healthcare professional. This recommendation is reinforced by clinical observations, which indicate that irritation or rash may occur in some individuals. Therefore, if any signs of irritation or rash develop, patients should promptly seek medical advice.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ourui One Facial Bump Refining Essence (salicylic acid 0.25% facial bump refining essence). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Ourui One Facial Bump Refining Essence.
Details

Pediatric Use

Pediatric patients under 2 years of age should not be administered this medication due to safety concerns. The efficacy and safety of this treatment have not been established in this age group, and caution is advised when considering its use in pediatric populations.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no specific information available regarding the use of this drug in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center if the product is swallowed. It is important to inform patients that this product is not recommended for use in children under 2 years of age or on open skin wounds.

Patients should be instructed to discontinue use and consult a healthcare professional if they experience any irritation or rash. Additionally, providers should emphasize the importance of keeping the product away from the eyes, ears, mouth, and any open or broken skin areas. In the event of contact with the eyes, patients should be advised to rinse their eyes thoroughly with water.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, shady place to maintain its integrity and effectiveness. Proper storage conditions are crucial to ensure the product remains within the recommended temperature range, thereby preventing degradation. Special handling requirements should be observed to protect the product from exposure to direct sunlight and extreme temperatures.

Additional Clinical Information

The product is administered topically, with a recommended application of once daily after cleansing and toning, or twice a day for a minimum duration of four weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Ourui One Facial Bump Refining Essence, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Ourui One Facial Bump Refining Essence, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.